Category: miscarriage
Montreal, November 17, 2009 -- More than six percent of expectant mothers in Quebec consume prescription drugs that are known to be harmful to their fetuses, according to a Université de Montréal investigation published in the British Journal of Obstetrics and Gynaecology.
New York, NY, October 20, 2009 -- Depression, anxiety disorders and sexual trauma have all been implicated as risk factors in lower urinary tract symptoms (LUTS) such as incontinence and overactive bladder. The exact nature of these associations is unknown.
Boston, Mass. -- With new prenatal tests for Down syndrome on the horizon promising to be safer, more accurate, and available to women earlier in pregnancy, the medical community must come together and engage in dialogue about the impact of existing and expected tests, argues a new leading article published Online First by Archives of Disease in Childhood.
A new type of fetal heart monitor could save the lives of unborn infants in complicated pregnancies, according to a study published in the International Journal of Engineering Systems Modelling and Simulation.
FAIRFAX, Va. -- Uterine fibroid embolization -- a minimally invasive interventional radiology treatment for women that cuts off blood flow to painful fibroids to kill the tumors -- is highlighted as an appropriate treatment for women in a Clinical Therapeutics article in the Aug. 13 issue of the New England Journal of Medicine.
People are likely being exposed to the commonly used chemical bisphenol A (BPA) at levels much higher than the recommended safe daily dose, according to a new study in monkeys. The results will be presented Thursday at The Endocrine Society's 91st Annual Meeting in Washington, D.C.
Women who take non-steroidal anti-inflammatory drugs (NSAIDs) or aspirin during pregnancy increase their risk of miscarriage by 80 per cent, finds a study in this week's BMJ. Researchers in California interviewed 1,055 pregnant women immediately after their pregnancy was confirmed. They asked the women about their drug use since they became pregnant, their reproductive history, known or potential risk factors for miscarriage, and sociodemographic characteristics. They found that use of NSAIDs during pregnancy increased the risk of miscarriage by 80%.
A non-invasive test which allows faster, cheaper, and less risky prenatal genetic screening was announced by Australian researchers at the International Genetics Congress in Melbourne today. The new test can also be performed much earlier in pregnancy, say its developers Dr Ian Findlay and Mr Darryl Irwin of the Australian Genome Research Facility in Brisbane. It should open the opportunity of prenatal genetic testing to a wider group of women. "This test will focus conventional prenatal testing much more effectively," said Dr Findlay.
Scientists have discovered that the genetic mutation that causes the childhood cancer retinoblastoma routinely triggers fetal death and miscarriage in laboratory animals by disrupting the normal functions of the placenta, a finding that may force researchers to reevaluate the powerful Rb gene and the role it plays in causing cancer.
